Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJC2N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,064
Award facts
- Contract value 100% obligated
- $24,063.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,063.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Wegovy 2.4 mg/0.75 mL pens on December 4, 2025, with completion scheduled for December 5, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems through its extensive portfolio of pharmaceutical and medical supply contracts with the Defense Logistics Agency. This delivery order for Wegovy, a diabetes and weight-management medication, aligns with AmerisourceBergen's demonstrated capability to supply a comprehensive range of brand-name and generic medications to support military healthcare programs. As a prime vendor under the DLA Pharmaceutical Prime Vendor Global Program, the company maintains competitively awarded contracts demonstrating its ability to fulfill federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FJC2N?
SPE2DR26FJC2N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FJC2N worth?
The government has obligated $24,064 on SPE2DR26FJC2N.
Is contract SPE2DR26FJC2N an order under another contract?
Yes. SPE2DR26FJC2N is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJC2N competed?
The extent of competition for SPE2DR26FJC2N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award